ExodusPoint Capital Management’s MacroGenics MGNX Stock Holding History

ExodusPoint Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-66,894	Closed	-$312K	–	1827
2023 Q3	$312K	Buy	66,894 +55,813	+504%	+$278K	﹤0.01%	1410
2023 Q2	$59K	Buy	+11,081	New	+$68.4K	﹤0.01%	1770
2022 Q4	–	Sell	-28,892	Closed	-$100K	–	1931
2022 Q3	$100K	Sell	28,892 -33,789	-54%	-$129K	﹤0.01%	1743
2022 Q2	$185K	Buy	+62,681	New	+$329K	﹤0.01%	1671
2022 Q1	–	Sell	-65,213	Closed	-$1.05M	–	2488
2021 Q4	$1.05M	Sell	65,213 -13,164	-17%	-$248K	0.01%	1043
2021 Q3	$1.64M	Buy	+78,377	New	+$1.89M	0.02%	804
2020 Q3	–	Sell	-27,414	Closed	-$765K	–	2042
2020 Q2	$765K	Buy	+27,414	New	+$476K	0.02%	876
2020 Q1	–	Sell	-16,353	Closed	-$178K	–	1426
2019 Q4	$178K	Buy	+16,353	New	+$162K	﹤0.01%	1357

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

ExodusPoint Capital Management's MGNX Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of MacroGenics (MGNX) in Q4 2023, closing a stake of 66,894 shares — an estimated $312K sold.

ExodusPoint Capital Management first reported a position in MGNX in Q4 2019 and held it in 8 quarters. The position peaked at $1.64M in Q3 2021. 142 funds tracked by Wall St. Rank hold MGNX as of Q4 2023.

ExodusPoint Capital Management reported no remaining MacroGenics position as of Q4 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 66,894 MacroGenics shares in Q4 2023, an estimated $312K.
ExodusPoint Capital Management first reported a position in MacroGenics in Q4 2019 and held it in 8 quarters.
ExodusPoint Capital Management's MacroGenics position peaked at $1.64M in Q3 2021.
142 funds tracked by Wall St. Rank held MacroGenics as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.